Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung and Pleural Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Not applicableLooking for participantsNCT00033137
What this trial is testing

Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer

Who this might be right for
Kidney NeoplasmsKidney CancerPneumothorax+1 more
National Cancer Institute (NCI) 950
Testing effectiveness (Phase 2)UnknownNCT02755675
What this trial is testing

UPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Who this might be right for
Non-small Cell Lung CancerMalignant Pleural MesotheliomaLarge Cell Neuroendocrine Carcinoma of the Lung
Rigshospitalet, Denmark 120
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)UnknownNCT00030459
What this trial is testing

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
British Thoracic Society
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06416930
What this trial is testing

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Who this might be right for
Pleural Mesothelioma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Not applicableUnknownNCT05910112
What this trial is testing

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

Who this might be right for
Pleural DiseasesPleural MesotheliomaPneumothorax+7 more
University of Oxford 2,000
Early research (Phase 1)UnknownNCT00006216
What this trial is testing

Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

Who this might be right for
Malignant Mesothelioma
Louisiana State University Health Sciences Center in New Orleans
Testing effectiveness (Phase 2)Study completedNCT00126581
What this trial is testing

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more
National Cancer Institute (NCI) 188
Not applicableLooking for participantsNCT06886672
What this trial is testing

Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS

Who this might be right for
Mesothelioma, Malignant Pleural
Fondazione IRCCS Policlinico San Matteo di Pavia 60
Not applicableStudy completedNCT05308966
What this trial is testing

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Who this might be right for
Malignant Pleural MesotheliomaUnresectable Malignant Neoplasm
Groupe Francais De Pneumo-Cancerologie 204
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131345
What this trial is testing

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMesothelioma
National Cancer Center, China 55
Early research (Phase 1)Study completedNCT00052338
What this trial is testing

Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT00003034
What this trial is testing

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Who this might be right for
Malignant Mesothelioma
Alfacell 300
Early research (Phase 1)Study completedNCT01998529
What this trial is testing

Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00004254
What this trial is testing

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 25
Not applicableUnknownNCT04887545
What this trial is testing

Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients

Who this might be right for
Lung CancerMalignancy
Universidade Nova de Lisboa 200
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00509041
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 46
Next Page